Abuelezz NZ, Nasr FE, AbdulKader MA et al (2021) MicroRNAs as potential orchestrators of alzheimer’s Disease-Related pathologies: insights on current status and future possibilities. Front Aging Neurosci 13:743573. https://doi.org/10.3389/FNAGI.2021.743573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agrawal RR, Larrea D, Xu Y et al (2022) Alzheimer’s-Associated upregulation of Mitochondria-Associated ER membranes after traumatic brain injury. Cell Mol Neurobiol 2022 43:5. https://doi.org/10.1007/S10571-022-01299-0

Article  Google Scholar 

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI et al (2025) Targeting of PP2 A/GSK3β/PTEN axis in alzheimer disease: the mooting Evidence, Divine, and devil. Cell Mol Neurobiol 2025 45(1 45):36. https://doi.org/10.1007/S10571-025-01554-0

Article  CAS  Google Scholar 

Alquezar C, Arya S, Kao AW (2021) Tau Post-translational modifications: dynamic Transformers of Tau Function, Degradation, and aggregation. Front Neurol 11:595532. https://doi.org/10.3389/FNEUR.2020.595532

Article  PubMed  PubMed Central  Google Scholar 

Alves VC, Carro E, Figueiro-Silva J (2024) Unveiling DNA methylation in alzheimer’s disease: a review of array-based human brain studies. Neural Regen Res 19:2365–2376. https://doi.org/10.4103/1673-5374.393106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Rafiei H, Mohammadinejad R et al (2020) Potential therapeutic effects of Curcumin mediated by JAK/STAT signaling pathway: A review. Phytother Res 34:1745–1760. https://doi.org/10.1002/PTR.6642

Article  CAS  PubMed  Google Scholar 

Bai B, Vanderwall D, Li Y et al (2021) Proteomic landscape of alzheimer’s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegeneration 2021 16(1):1–16. https://doi.org/10.1186/S13024-021-00474-Z

Article  Google Scholar 

Baier A, Szyszka R (2022) CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders. Front Mol Biosci 9:916063. https://doi.org/10.3389/FMOLB.2022.916063

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balmik AA, Chinnathambi S (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease. Cell Communication and Signaling 2021 19:1 19:51-. https://doi.org/10.1186/S12964-021-00732-Z

Baracaldo-Santamaría D, Avendaño-Lopez SS, Ariza-Salamanca DF et al (2023) Role of calcium modulation in the pathophysiology and treatment of alzheimer’s disease. Int J Mol Sci 24:9067. https://doi.org/10.3390/IJMS24109067

Article  PubMed  PubMed Central  Google Scholar 

Bertozzi A, Toscanelli W, Castellitto G et al (2025) SUMOylation balance: a key determinant in synapse physiology. Front Physiol 16:1675598. https://doi.org/10.3389/FPHYS.2025.1675598

Article  PubMed  PubMed Central  Google Scholar 

Buszka A, Pytyś A, Colvin D et al (2023) S-Palmitoylation of synaptic proteins in neuronal plasticity in normal and pathological brains. Cells 2023 12. https://doi.org/10.3390/CELLS12030387

Castro-Alvarez JF, Uribe-Arias A, Cardona-Gómez GP (2015) Cyclin-Dependent kinase 5 targeting prevents β-Amyloid aggregation involving glycogen synthase kinase 3β and phosphatases. J Neurosci Res 93:1258–1266. https://doi.org/10.1002/JNR.23576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen W, Zhao H, Li Y (2023) Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduction and Targeted Therapy 2023 8:1 8:333-. https://doi.org/10.1038/s41392-023-01547-9

Cuddy LK, Alia AO, Salvo MA et al (2022) Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice. Mol Neurodegeneration 2022 17:1. https://doi.org/10.1186/S13024-022-00561-9

Article  Google Scholar 

D’mello SR (2021) When good kinases go rogue: GSK3, p38 MAPK and CDKs as therapeutic targets for alzheimer’s and huntington’s disease. Int J Mol Sci 2021 22:22. https://doi.org/10.3390/IJMS22115911

Article  Google Scholar 

Dongdem JT, Dawson SP, Layfield R et al (2024) Ubiquitin: structure and function. https://doi.org/10.5772/INTECHOPEN.112091

Dunning EE, Decourt B, Zawia NH et al (2024) Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review. Neurology and Therapy 2024 13:4 13:975–1013. https://doi.org/10.1007/S40120-024-00614-9

Du Y, Yu Z, Li C et al (2025) The role of Statins in dementia or alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies. Front Pharmacol 16. https://doi.org/10.3389/FPHAR.2025.1473796

Engin AB, Engin A (2021) Alzheimer’s disease and protein kinases. Adv Exp Med Biol 1275:285–321. https://doi.org/10.1007/978-3-030-49844-3_11

Article  CAS  PubMed  Google Scholar 

Foster JB, Lashley R, Zhao F et al (2019) Enhancement of tripartite synapses as a potential therapeutic strategy for alzheimer’s disease: a preclinical study in rTg4510 mice. Alzheimer’s Res Therapy 2019 11(1 11):75–. https://doi.org/10.1186/S13195-019-0530-Z

Article  Google Scholar 

Gorantla NV, Chinnathambi S (2018) Tau protein squired by molecular chaperones during alzheimer’s disease. J Mol Neurosci 66:356–368. https://doi.org/10.1007/S12031-018-1174-3/METRICS

Article  CAS  PubMed  Google Scholar 

Guix FX, Sartório CL, Ill-Raga G (2019) BACE1 translation: at the crossroads between alzheimer’s disease neurodegeneration and memory consolidation. J Alzheimers Dis Rep 3:113–148. https://doi.org/10.3233/ADR-180089;REQUESTEDJOURNAL:JOURNAL:ALRA;WEBSITE:WEBSITE:SAGE;ISSUE:ISSUE:DOI

Article  PubMed  PubMed Central  Google Scholar 

Hamano T, Enomoto S, Shirafuji N et al (2021) Autophagy and Tau Protein. Int J Mol Sci 2021 22:7475. https://doi.org/10.3390/IJMS22147475

Hampel H, Vassar R, De Strooper B et al (2021) The β-Secretase BACE1 in alzheimer’s disease. Biol Psychiatry 89:745–756. https://doi.org/10.1016/J.BIOPSYCH.2020.02.001

Article  CAS  PubMed  Google Scholar 

Hassan M, Yasir M, Shahzadi S et al (2024a) Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases. Biomedicines 2024, Vol 12, Page 1097 12:1097. https://doi.org/10.3390/BIOMEDICINES12051097

Hassan M, Yasir M, Shahzadi S et al (2024b) Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases. Biomedicines 2024, Vol 12, 12:. https://doi.org/10.3390/BIOMEDICINES12051097

Henley JM, Carmichael RE, Wilkinson KA (2018) Extranuclear sumoylation in neurons. Trends Neurosci 41:198–210. https://doi.org/10.1016/j.tins.2018.02.004

Article  CAS  PubMed  Google Scholar 

Henneberg LT, Schulman BA (2021) Decoding the messaging of the ubiquitin system using chemical and protein probes. Cell Chem Biol 28:889–902. https://doi.org/10.1016/J.CHEMBIOL.2021.03.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hering H, Graham D, Ousson S et al (2013) Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for alzheimer’s disease and tauopathies. Mol Neurodegeneration 2013(8:1):8O17–. https://doi.org/10.1186/1750-1326-8-S1-O17

Article  Google Scholar 

Hiramatsu M, Takiguchi O, Nishiyama A, Mori H (2010) Cilostazol prevents amyloid β peptide(25–35)-induced memory impairment and oxidative stress in mice. Br J Pharmacol 161:1899–1912. https://doi.org/10.1111/J.1476-5381.2010.01014.X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jadiya P, Garbincius JF, Elrod JW (2021) Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling. Acta Neuropathologica Communications 2021 9:1 9:124-. https://doi.org/10.1186/S40478-021-01224-4

Jia F, Fu L (2025) Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer’s Disease. Molecular Neurobiology 2025 62:6 62:7747–7761. https://doi.org/10.1007/S12035-025-04739-2

Jin J, Zhi X, Wang X, Meng D (2021) Protein palmitoylation and its pathophysiological relevance. J Cell Physiol 236:3220–3233. https://doi.org/10.1002/JCP.30122

Article  CAS  PubMed  Google Scholar 

Kelliny S, Zhou XF, Bobrovskaya L (2025) Alzheimer’s disease and frontotemporal dementia: A review of pathophysiology and therapeutic approaches. J Neurosci Res 103:e70046. https://doi.org/10.1002/JNR.70046

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kennedy ME, Stamford AW, Chen X et al (2016) The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in alzheimer’s disease patients. Sci Transl Med. https://doi.org/10.1126/SCITRANSLMED.AAD9704. 8:

Article  PubMed  Google Scholar 

Kielbasa W, Goldsmith P, Donnelly KB et al (2024) Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of alzheimer’s disease. Alzheimer’s Dementia: Translational Res Clin Interventions 10:e70020. https://doi.org/10.1002/TRC2.70020

Article  Google Scholar 

Kilgore M, Miller CA, Fass DM et al (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of alzheimer’s disease. Neuropsychopharmacology 35:870–880. https://doi.org/10.1038/NPP.2009.197

Article  CAS